Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ABL1 | P00519 | 1/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | ALPI | P09923 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALPG | P10696 | 1/20 | 0.56 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | GALK1 | P51570 | 1/20 | 0.56 |
| ▸ | CASP7 | P55210 | 1/20 | 0.56 |
| ▸ | CASP6 | P55212 | 1/20 | 0.56 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.56 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.56 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.56 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9001318 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL8838912 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL18718056 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL9155988 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL20056672 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL15504372 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL117781 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL9849387 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL5026366 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL | |
| SCHEMBL18733414 | 1.00 | SLC6A2 (0.57) | SLC6A2SYNJ2KDM4EABL1ALPL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109912642-A | Method for stereoselective synthesis of β -2-deoxyglycosidic bond | 四川轻化工大学 | 2019-06-21 | — | — | CN | disclosed |
| EP-3116886-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | Faculdade De Ciências da Universidade de Lisboa (PT) | 2017-01-18 | — | — | EP | disclosed |
| WO-2015137838-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | EXTREMOCHEM, LDA. (PT) | 2015-09-17 | — | — | WO | disclosed |
| US-8389565-B2 | Antidiabetic agents; controlling carbohydrate metabolism | SIMON FRASER UNIVERSITY (CA) | 2013-03-05 | — | — | US | disclosed |
| CN-101165047-B | Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method | DAIICHI ASUBIO PHARMA CO LTD (JP) | 2010-10-20 | — | — | CN | disclosed |
| CN-100537585-C | Glycolipid derivative, process for producing the same, intermediate for the synthesis thereof, and process for producing the same | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2009-09-09 | — | — | CN | disclosed |
| CN-101437809-A | Glycosidase inhibitors and methods of synthesizing same | UNIV FRASER SIMON (CA) | 2009-05-20 | — | — | CN | disclosed |
| EP-1999124-A1 | GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME | SIMON FRASER UNIVERSITY (CA) | 2008-12-10 | — | — | EP | disclosed |
| CN-101165047-A | Glycolipid derivative and its manufacturing method, and its synthesizing intermediate and its manufacturing method | DAIICHI ASUBIO PHARMA CO LTD (JP) | 2008-04-23 | — | — | CN | disclosed |
| WO-2007098597-A1 | GLYCOSIDASE INHIBITORS AND METHODS OF SYNTHESIZING SAME | SIMON FRASER UNIVERSITY (CA) | 2007-09-07 | — | — | WO | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |
| EP-0729648-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-09-04 | — | — | EP | disclosed |
| EP-0456948-B1 | Method for the preparation of polyphosphorylated derivatives of galactopyranosides with a potential insulin-like activity | EUROPHARMA SA (ES) | 1995-08-30 | — | — | EP | disclosed |
| WO-1995012219-A1 | STABILISED ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND REDOX CELLS AND BATTERIES CONTAINING STABILISED ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1995-05-04 | — | — | WO | disclosed |
| EP-0650492-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1995-05-03 | — | — | EP | disclosed |
| EP-0643718-A1 | IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?C AND LacNAc COMPOUNDS | ALBERTA RESEARCH COUNCIL (CA) | 1995-03-22 | — | — | EP | disclosed |
| EP-0591254-A1 | IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWIS?X AND LEWIS?A COMPOUNDS | GLYCOMED INCORPORATED (US) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993024506-A1 | IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISC AND LacNAc COMPOUNDS | ALBERTA RESEARCH COUNCIL (CA) | 1993-12-09 | — | — | WO | disclosed |
| WO-1993024505-A1 | REDUCING INFLAMMATION BY TIME DEPENDENT ADMINISTRATION OF OLIGOSACCHARIDES GLYCOSIDES RELATED TO BLOOD GROUP DETERMINANTS | ALBERTA RESEARCH COUNCIL (CA) | 1993-12-09 | — | — | WO | disclosed |
| WO-1992022564-A1 | IMMUNOSUPPRESSIVE AND TOLEROGENIC MODIFIED LEWISX AND LEWISA COMPOUNDS | ALBERTA RESEARCH COUNCIL (CA) | 1992-12-23 | — | — | WO | disclosed |